Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000538.SZ

STRONG BUYREMOVE

Yunnan Baiyao Group Co.,Ltd · Healthcare · China · $13.2B · Avg Vol: $69M/d

91
StockRank
Q
71
V
53
M
57
P/E (TTM)
17.0x
ROE
12.8%
D/E
0.0x
Dividend %
3.1%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
AI CONVICTION THESIS

Yunnan Baiyao is a highly respected traditional Chinese medicine brand with a strong consumer moat, but it lacks any direct alignment with our 18-month macro themes.

COMPANY DESCRIPTION

Yunnan Baiyao Group is an iconic Chinese pharmaceutical and consumer healthcare company, globally renowned for its proprietary, state-secret Traditional Chinese Medicine (TCM) formulas used in wound healing and pain relief. The company has successfully leveraged its powerful brand equity to dominate the premium personal care market, particularly with its market-leading toothpaste line. Its vertically integrated business model spans TCM cultivation, pharmaceutical manufacturing, and a vast domestic distribution network.

FINANCIAL SUMMARY

Year2022202320242025CAGR
Revenue5.4B5.8B5.9B6.1B4.1%
EPS0.280.340.390.4315.0%
Shares1.8B1.8B1.8B1.8B-0.7%
Debt330M295M104M72M-39.8%
Equity5.7B5.9B5.7B5.9B1.3%
Op CF474M518M635M680M12.7%
Inv CF-933M77M-177M-293M—
Fin CF-404M-431M-1.0B-643M—
Loading...
PRICE (1M)-5.5%
7.187.357.517.687.84Apr 30May 26Jun 15
SMA 50SMA 200
Close
$7.41
RSI (14)
59.5
52W High
$8.56
From 52W High
0.9%

SCORE BREAKDOWN

Quality
71
ROIC
14.7%84.4
ROE
12.8%78.4
GP/Assets
22.3%50.9
Op. Margin
18.3%79.9
FCF/Assets
6.3%76.3
Piotroski
—55.8
Int. Cover
50.0x91.4
D/E Ratio
0.01x90.4
Current Ratio
2.74x49.3
Value
53
P/E (TTM)
17.0x66.7
EV/EBITDA
15.5x26.7
P/FCF
175.8x45.6
P/B
2.1x53.4
P/S
2.1x66.4
Div Yield
3.1%72.1
Momentum
57
52W High %
87%84.4
RS 6M
-15%62.0
SMA 50/200
0.96x49.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+12%28.2
Q Growth
5%45.5

FUNDAMENTALS

Market Cap
$13.2B
P/E (Forward)
15.2x
Gross Margin
28.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000538.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
000538.SZYunnan Baiyao Group Co.,Ltd(you)$13.2B91STRONG BUY
002001.SZZhejiang NHU Company Ltd.$13.3B99STRONG BUY
000963.SZHuadong Medicine Co., Ltd$7.5B84STRONG BUY
3692.HKHansoh Pharmaceutical Group Company Limited$24.3B83STRONG BUY
000999.SZChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd.$6.0B87STRONG BUY
600329.SSTianjin Pharmaceutical Da Ren Tang Group Corporation Limited$4.6B87STRONG BUY
000513.SZLivzon Pharmaceutical Group Inc.$4.0B94STRONG BUY
2096.HKSimcere Pharmaceutical Group Limited$3.3B91STRONG BUY
000423.SZDong-E-E-Jiao Co., Ltd.$4.8B99STRONG BUY
002603.SZShijiazhuang Yiling Pharmaceutical Co., Ltd.$4.0B96STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Yunnan Baiyao Group Co.,Ltd (000538.SZ) — Stock Score Summary

Yunnan Baiyao Group Co.,Ltd (000538.SZ) has a MoatMap StockRank of 91/100 based on Quality (71/100), Value (53/100), and Momentum (57/100) factor scores. The current signal is STRONG BUY. Yunnan Baiyao is a highly respected traditional Chinese medicine brand with a strong consumer moat, but it lacks any direct alignment with our 18-month macro themes.

Yunnan Baiyao Group is an iconic Chinese pharmaceutical and consumer healthcare company, globally renowned for its proprietary, state-secret Traditional Chinese Medicine (TCM) formulas used in wound healing and pain relief. The company has successfully leveraged its powerful brand equity to dominate the premium personal care market, particularly with its market-leading toothpaste line. Its vertically integrated business model spans TCM cultivation, pharmaceutical manufacturing, and a vast domestic distribution network.

Key Financial Metrics

Price$7.41
Market Cap$13.2B
P/E (TTM)16.96
P/E (Forward)15.20
Price/Book2.12
Return on Equity12.8%
Return on Invested Capital14.7%
Debt/Equity0.77
Gross Margin28.7%
Operating Margin18.3%
Revenue Growth7.0%
Dividend Yield3.1%
Free Cash Flow$75M

Yunnan Baiyao Group Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Yunnan Baiyao Group Co.,Ltd’s (000538.SZ) StockRank?
MoatMap’s StockRank for Yunnan Baiyao Group Co.,Ltd (000538.SZ) is 91/100, with a Strong Buy signal. It is a composite of Quality (71), Value (53), and Momentum (57) factor ranks across MoatMap’s 19,000+ stock universe.
Does Yunnan Baiyao Group Co.,Ltd have an economic moat?
Yunnan Baiyao Group Co.,Ltd (000538.SZ) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Yunnan Baiyao Group Co.,Ltd a buy, hold, or sell?
MoatMap’s current signal for Yunnan Baiyao Group Co.,Ltd (000538.SZ) is Strong Buy, based on a StockRank of 91/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Yunnan Baiyao Group Co.,Ltd in?
Yunnan Baiyao Group Co.,Ltd (000538.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks000538.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock